Clinical Trials Logo

Lung Cancer clinical trials

View clinical trials related to Lung Cancer.

Filter by:

NCT ID: NCT02936947 Terminated - Breast Cancer Clinical Trials

Study to Evaluate the Benefit of a High Frequency Ventilation System During Lung or Breast Cancer Radiotherapy Treatment

Start date: July 2016
Phase: N/A
Study type: Interventional

That study combines High Frequency Percussive Ventilation (HFPV) with radiotherapy treatment in patients with tumors that are moving with respiration like breast or lung cancers. The use of a High Frequency Percussive Ventilation system leads to the cessation of respiratory motions while administering radiotherapy (RT) to tumors which allows a reduction of the amount of irradiated normal tissues and which potentially decrease radiation-induced collateral damages.

NCT ID: NCT02883790 Terminated - Breast Cancer Clinical Trials

Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients

Start date: October 2015
Phase: N/A
Study type: Interventional

The aim of this placebo-controlled randomized study is to evaluate the effects of Melatonin 1mg/Zn 30% VNR/Mg 100% VNR (food supplement) in the management on sleep quality and mood alteration in cancer patients

NCT ID: NCT02768337 Terminated - Breast Cancer Clinical Trials

Cambridge Brain Mets Trial 1

CamBMT1
Start date: March 10, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Proof of principle phase 1b / randomised phase 2 study of afatinib penetration into cerebral metastases for patients undergoing neurosurgical resection, both with and without prior low-dose, targeted radiotherapy.

NCT ID: NCT02759679 Terminated - Lung Cancer Clinical Trials

Canine-Assisted Profiling of Lung Cancer From Human Breath

Start date: May 2016
Phase: N/A
Study type: Interventional

The study aims to optimize and define a reproducible and non-invasive method for canine assisted lung cancer detection, using human breath samples from patients and controls for training and testing purposes.

NCT ID: NCT02715102 Terminated - Lung Cancer Clinical Trials

Circulating Tumor DNA in Patients at High Risk for Lung Cancer

Start date: June 2016
Phase: N/A
Study type: Observational

Patients who are about to undergo a diagnostic or therapeutic bronchoscopy or thoracic surgery without a distant history of cancer will have their blood drawn for measurement of circulating tumor DNA (ctDNA) to validate the utility of molecular diagnostic assays for the early detection of lung cancer.

NCT ID: NCT02695680 Terminated - Lung Cancer Clinical Trials

Lung SBRT Motion Management (GCC 1619)

Start date: October 27, 2017
Phase:
Study type: Observational

Real-time optical surface monitoring data will be acquired from 44 human patients with primary or metastatic lung lesions during and after their 4DCT scan (standard-of-care at our institution). A patient-specific 4D model will be developed using the raw 4DCT projections time-correlated with real-time surface monitoring. In addition, before delivering each dose fraction (3 - 5 for lung SBRT), we will acquire three 15s kV fluoroscopic image acquisitions, time-correlated with optical surface monitoring. The acquisitions will be distributed over three well-spaced beam angles, e.g., every 4th angle for a 12-field plan.

NCT ID: NCT02694380 Terminated - Breast Cancer Clinical Trials

Measuring the Effect of Radiation Therapy on Patient Activity Levels

Start date: July 2015
Phase:
Study type: Observational

The goal of this study is to measure the effect of radiation therapy on the activity levels of patients. This will be achieved by tracking their activity levels during a treatment course of radiation therapy.

NCT ID: NCT02676050 Terminated - Lung Cancer Clinical Trials

Visualising c-MET and Activated Neutrophils in Lung Cancer

DUAL
Start date: October 4, 2019
Phase: Early Phase 1
Study type: Interventional

Lung cancer is currently a major health problem in the UK. Despite being one of the most common cancers, lung cancer has a poor prognosis compared to other types of cancer and is the leading cause of cancer death in the world. As opposed to other organs, the lung is highly susceptible to inflammatory insults, for example from bacterial infection-induced and tobacco-induced inflammation. It has long been known that the cellular microenvironment that nurtures tumour growth and development is linked to sites of chronic inflammation but molecular insights into how external inflammation boosts or inhibits cancer in the lungs remains unclear. This study aims to directly visualise the expression of a well known marker of cancerous tissue, c-MET, and the activity of neutrophils in human lung cancer in vivo in situ using fibre-based endomicroscopy.

NCT ID: NCT02673021 Terminated - Lung Cancer Clinical Trials

MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

MARK 1A
Start date: June 8, 2016
Phase: N/A
Study type: Interventional

Does lung ablation improve clinical outcomes for patients deemed to be surgically high-risk?

NCT ID: NCT02644252 Terminated - Lung Cancer Clinical Trials

Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer

Toco-Pulm
Start date: January 2016
Phase: Phase 3
Study type: Interventional

There is a need for improving the effect of first-line chemotherapy for lung cancer patients, preferably by using an approach with none or very few side effects. In this trial the investigators incorporate δ-tocotrienol/placebo as a nutritional supplement on top of standard chemotherapy for patients with advanced non-small cell lung cancer.